Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Homviotensin
- Development stage
- Unknown
- Lead developer
- Homviora Arzneimittel Dr. Hagedorn
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Homviotensin is a homeopathic combination drug developed and marketed by Homviora Arzneimittel Dr. Hagedorn GmbH & Co. KG. It is indicated for the treatment of blood pressure disorders, specifically mild hypertension and fluctuating blood pressure. The preparation is a multi-ingredient formulation containing four plant-derived active ingredients: *Cactus* (D1), *Viscum album* (mistletoe mother tincture), *Rauwolfia* (D3), and *Crataegus* (hawthorn mother tincture). As a homeopathic product, it is purported to regulate and stabilize blood pressure values naturally while alleviating associated symptoms such as dizziness, headaches, and circulatory problems. It has been evaluated in Phase 2 clinical trials comparing its efficacy and sedative effects (measured via EEG theta power) to conventional treatments like metoprolol.
- Brand names
- Homviotensin
Beyond the preview
Go deeper on Homviotensin.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Homviotensin.